UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Local Effects Following Single and Repeat Intra-Articular Injections of Triamcinolone Acetonide Extended-Release: Results from Three Nonclinical Toxicity Studies in Dogs

Rheumatology and therapy., 2018-12, Vol.5 (2), p.475-498

2018

Volltextzugriff (PDF)

An intra-articular, extended-release formulation of triamcinolone acetonide prolongs and amplifies analgesic effect in patients with osteoarthritis of the knee: a randomized clinical trial

Journal of bone and joint surgery. American volume, 2015-06, Vol.97 (11), p.877-888

2015

Volltextzugriff (PDF)

Machine-learning, MRI bone shape and important clinical outcomes in osteoarthritis: data from the Osteoarthritis Initiative

Annals of the rheumatic diseases, 2021-04, Vol.80 (4), p.502-508

2021

Volltextzugriff (PDF)

Brief Report: A Phase IIb Trial of a Novel Extended‐Release Microsphere Formulation of Triamcinolone Acetonide for Intraarticular Injection in Knee Osteoarthritis

Arthritis & rheumatology (Hoboken, N.J.), 2018-02, Vol.70 (2), p.204-211

2018

Volltextzugriff (PDF)

Effects of a Single Intra-Articular Injection of a Microsphere Formulation of Triamcinolone Acetonide on Knee Osteoarthritis Pain: A Double-Blinded, Randomized, Placebo-Controlled, Multinational Study

Journal of bone and joint surgery. American volume, 2018-04, Vol.100 (8), p.666-677

2018

Volltextzugriff (PDF)

Efficacy and Safety of FX201, a Novel Intra-Articular IL-1Ra Gene Therapy for Osteoarthritis Treatment, in a Rat Model

Human gene therapy, 2022-05, Vol.33 (9-10), p.541-549

2022

Volltextzugriff (PDF)

Triamcinolone acetonide extended-release in patients with osteoarthritis and type 2 diabetes: a randomized, phase 2 study

Rheumatology (Oxford, England), 2018-12, Vol.57 (12), p.2235-2241

2018

Volltextzugriff (PDF)

Brief Report: A Phase II b Trial of a Novel Extended‐Release Microsphere Formulation of Triamcinolone Acetonide for Intraarticular Injection in Knee Osteoarthritis

Arthritis & rheumatology (Hoboken, N.J.), 2018-02, Vol.70 (2), p.204-211

2018

Volltextzugriff (PDF)

Effect Of Triamcinolone Acetonide Extended-release On Synovial Inflammation In Patients With Osteoarthritis Of The Knee: 3699 Board #16

Medicine and science in sports and exercise, 2020-07, Vol.52 (7S), p.1010-1010

2020

Volltextzugriff (PDF)

Effects of Central Muscarinic-1 Receptor Stimulation on Blood Pressure Regulation

Hypertension (Dallas, Tex. 1979), 1997-03, Vol.29 (3), p.828-834

1997

Volltextzugriff (PDF)

Brain proton magnetic resonance spectroscopy (1H-MRS) in Alzheimer's disease: changes after treatment with xanomeline, an M1 selective cholinergic agonist

The American journal of psychiatry, 1997-10, Vol.154 (10), p.1459-1461

1997

Volltextzugriff (PDF)

Brain Proton Magnetic Resonance Spectroscopy in Alzheimer Disease: Changes After Treatment With Xanomeline

The American journal of geriatric psychiatry, 2002-01, Vol.10 (1), p.81-88

2002

Volltextzugriff (PDF)

Efficacy of xanomeline in Alzheimer disease : Cognitive improvement measured using the computerized neuropsychological test battery (CNTB)

Alzheimer disease and associated disorders, 1998-12, Vol.12 (4), p.304-312

1998

Volltextzugriff (PDF)

Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease

Archives of neurology (Chicago), 1997-04, Vol.54 (4), p.465-473

1997

Volltextzugriff (PDF)

Quality-of-life assessment in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines

Alzheimer disease and associated disorders, 1997, Vol.11 Suppl 3, p.56-60

1997

Volltextzugriff (PDF)

Objective psychometric tests in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines

Alzheimer disease and associated disorders, 1997, Vol.11 Suppl 3, p.34-38

1997

Volltextzugriff (PDF)

S-16-4 Xanomeline: The first study of the safety and efficacy of an M1 agonist in mild and moderate Alzheimer's disease

European neuropsychopharmacology, 1995-09, Vol.5 (3), p.205-205

1995

Volltextzugriff (PDF)

SAT-5-3 Xanomeline in mild and moderate Alzheimer's disease; the effects of a novel M1 agonist on behavior

European neuropsychopharmacology, 1995-09, Vol.5 (3), p.254-255

1995

Volltextzugriff (PDF)

Growing Optic Nerve Fibers Follow Neighbors during Embryogenesis

Proceedings of the National Academy of Sciences - PNAS, 1980-07, Vol.77 (7), p.4374-4378

1980

Volltextzugriff (PDF)

A more rational approach to new-product development

Harvard business review, 2008-03, Vol.86 (3), p.96-134

2008

Volltextzugriff (PDF)

Serial reconstruction of microtubular arrays within dendrites of the cat retinal ganglion cell: The cytoskeleton of a vertebrate dendrite

Brain research, 1983-01, Vol.259 (2), p.193-206

1983

Volltextzugriff (PDF)

Xanomeline: A selective muscarinic agonist for the treatment of Alzheimer's disease

Drug development research, 1997-02, Vol.40 (2), p.158-170

1997

Volltextzugriff (PDF)

THE SELF-ASSEMBLY OF THE EMBRYONIC OPTIC NERVE INTO A RETINOTOPICALLY ORDERED ARRAY

BODICK, NEIL CLAYTON

1980

Volltextzugriff (PDF)

The Eidetic System: Mechanisms for Knowledge Representation in Image Intensive Disciplines

Proceedings - Symposium on Computer Application in Medical Care, 1989, p.975-976

1989

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(18)

Publikationsform

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(12)
Science & Technology
(12)
Humans
(11)
Aged
(7)
Alzheimer Disease - Drug Therapy
(7)
Female
(7)
Male
(7)
Middle Aged
(6)
Treatment Outcome
(6)
Double-Blind Method
(5)
Neurosciences & Neurology
(5)
Pyridines - Therapeutic Use
(5)
Thiadiazoles - Therapeutic Use
(5)
Aged, 80 And Over
(4)
Arthritis
(4)
Biological And Medical Sciences
(4)
Clinical Neurology
(4)
Injections, Intra-Articular
(4)
Medical Sciences
(4)
Muscarinic Agonists - Therapeutic Use
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Local Effects Following Single and Repeat Intra-Articular Injections of Triamcinolone Acetonide Extended-Release: Results from Three Nonclinical Toxicity Studies in Dogs

An intra-articular, extended-release formulation of triamcinolone acetonide prolongs and amplifies analgesic effect in patients with osteoarthritis of the knee: a randomized clinical trial

Machine-learning, MRI bone shape and important clinical outcomes in osteoarthritis: data from the Osteoarthritis Initiative

Brief Report: A Phase IIb Trial of a Novel Extended‐Release Microsphere Formulation of Triamcinolone Acetonide for Intraarticular Injection in Knee Osteoarthritis

Effects of a Single Intra-Articular Injection of a Microsphere Formulation of Triamcinolone Acetonide on Knee Osteoarthritis Pain: A Double-Blinded, Randomized, Placebo-Controlled, Multinational Study

Efficacy and Safety of FX201, a Novel Intra-Articular IL-1Ra Gene Therapy for Osteoarthritis Treatment, in a Rat Model

Triamcinolone acetonide extended-release in patients with osteoarthritis and type 2 diabetes: a randomized, phase 2 study

Brief Report: A Phase II b Trial of a Novel Extended‐Release Microsphere Formulation of Triamcinolone Acetonide for Intraarticular Injection in Knee Osteoarthritis

Effect Of Triamcinolone Acetonide Extended-release On Synovial Inflammation In Patients With Osteoarthritis Of The Knee: 3699 Board #16

Effects of Central Muscarinic-1 Receptor Stimulation on Blood Pressure Regulation

Brain proton magnetic resonance spectroscopy (1H-MRS) in Alzheimer's disease: changes after treatment with xanomeline, an M1 selective cholinergic agonist

Brain Proton Magnetic Resonance Spectroscopy in Alzheimer Disease: Changes After Treatment With Xanomeline

Efficacy of xanomeline in Alzheimer disease : Cognitive improvement measured using the computerized neuropsychological test battery (CNTB)

Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease

Quality-of-life assessment in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines

Objective psychometric tests in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines

S-16-4 Xanomeline: The first study of the safety and efficacy of an M1 agonist in mild and moderate Alzheimer's disease

SAT-5-3 Xanomeline in mild and moderate Alzheimer's disease; the effects of a novel M1 agonist on behavior

Growing Optic Nerve Fibers Follow Neighbors during Embryogenesis

A more rational approach to new-product development

Serial reconstruction of microtubular arrays within dendrites of the cat retinal ganglion cell: The cytoskeleton of a vertebrate dendrite

Xanomeline: A selective muscarinic agonist for the treatment of Alzheimer's disease

THE SELF-ASSEMBLY OF THE EMBRYONIC OPTIC NERVE INTO A RETINOTOPICALLY ORDERED ARRAY

The Eidetic System: Mechanisms for Knowledge Representation in Image Intensive Disciplines

Suchergebnisse filtern